---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-039587"
form_type: "8-K/A"
ticker: "CDT"
cik: "0001896212"
company_name: "CDT Equity Inc."
filed_at: "2026-08-21T13:27:22+00:00"
generated_at: "2026-08-21T13:28:08.499062+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# CDT Equity files amended 8-K for Sarborg investment; Sarborg 2025 revenue $4.6M, net loss $508K

## Summary
- Sarborg FY2025 revenue $4.6M, gross profit $4.2M, net loss $508K (vs. $98K revenue, $282K loss in 2024).
- Sarborg had $10K cash and $790K accumulated deficit at 12/31/25; going-concern doubt mitigated by founder guaranty.
- CDT's initial investment in Sarborg completed; audited financials and unaudited pro forma statements now filed as Exhibits 99.1/99.2.
- Sarborg is an agentic AI platform for drug repurposing and industrial signature analysis; material related-party revenue and deferred revenue.
- CDT's common stock (CDT) and warrants (CDTTW) trade on Nasdaq; no deal terms or acquisition price disclosed in this amendment.

## SEC filing metadata
- accession: 0001493152-26-039587
- form_type: 8-K/A
- ticker: CDT
- cik: 0001896212
- company_name: CDT Equity Inc.
- filed_at: 2026-08-21T13:27:22+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.01, 9.01, 1.01, 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1896212/000149315226039587/0001493152-26-039587-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1896212/000149315226039587/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-039587
- JSON: https://secwatch.observer/filing/0001493152-26-039587.json
- Plain text: https://secwatch.observer/filing/0001493152-26-039587.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.